We are…
CanaQuest Medical Corp is exploring the health benefits through science of medical cannabis.
Our focus…
Is on the development of proprietary products utilizing cannabis oil combined with other botanical extracts. Positive data from our research and pre-clinical trials has put us in a position to bring our first CBD and THC based products to market.
Our status…
· License - approval has been awarded from Health Canada for a medical cannabis License without possession to sell/purchase, import/export medical cannabis,
· Product - Mentabinol™ - a THC formulated commercial ready product, which blocks the negative side effects from cannabis THC consumption,
· Supply – access to an unlimited supply of cannabis,
· Production capacity – access to high production capacity,
· Distribution – established access to global distribution channels.
Research and Product Development…
The Company has engaged two Canadian universities, Western University and the University of Waterloo, to provide research, and to create these formulations and products. Our research is focused on mitigation of the spread of cancerous tumors and the development of novel pharmacotherapies for mental health. This has led to the discovery of a formula that blocks the negative psychotic effects of THC consumption.
Marketing and Sales…
Our extremely experienced US Branding and Marketing team has been selected and our execution plan is in place to roll out our first CBD formulated - science backed products - providing market development strategies to build sales in the food, nutrition and vitamin & dietary supplement industries.
CanaQuest Medical Corp. is a publicly traded company listed on the OTC under the ticker symbol CANQF. This is not investment advice. Please view the disclaimer found on this website.
